AlphaYou
Overview
Smart money at a glance
Filings to Oct 12, 2026Net selling: insiders sold $16M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $35K to $99K in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$16M netNet selling
- CongressSTOCK Act, last 180 days
- +$35K to +$99K netNet buying
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 8 added, 4 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 11- Open
- $1,153.56
- 52-wk high
- $1,292.65
- High
- $1,179.82
- 52-wk low
- $778.94
- Low
- $1,151.67
- Prev close
- $1,169.60
- Mkt cap
- $1.05T
- P/E
- 39.6x
- Volume
- 1.38M
- Fwd P/E
- 24.4x
- Beta
- 0.45
- Div yield
- 0.55%
- P/S
- 13.2x
- P/B
- 30.3x
- Profit margin
- +33.5%
- Op margin
- +54.2%
- ROE
- +102.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about LLY filings
Are insiders buying or selling Eli Lilly and Company (LLY) stock?
Net selling: insiders sold $16M and bought $0 of LLY stock on the open market in the 90 days to Oct 12, 2026, according to SEC Form 4 filings. $16M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Jonsson, Patrik (EVP & President, LLY Int'l), who sold $7.6M. The latest filing was on Aug 18, 2026.
Which members of Congress have traded LLY recently?
Rep. Michael Rulli (R) sold $1K to $15K on Jul 1, 2026, disclosed 37 days later. Rep. Gilbert Cisneros (D) bought $50K to $100K on Jun 10, 2026, disclosed 22 days later. In total, 2 members disclosed 2 LLY trades with trade dates in the last 180 days, filed a median 30 days after trading.
How current is this LLY smart-money data?
This summary uses filings available on Oct 12, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position, insiders have been net selling, and 1 fin-fluencer is discussing it.
What funds are doing
Buys/Adds (2)
- CI
Citadel
$911.7M
added
- SU
Susquehanna
$282.2M
added
Sells/Trims (1)
- QR
Qube Research
$242.1M
trimmed
What insiders are doing
What Congress is doing
Buys (1)
Sells (2)
How top traders are positioned
Trader 295Long
$39K
position
Trader 447Short
$8K
position
Trader E15Long
$6K
position
Show all 5 positionsShow fewer positions
Trader 5B7Long
$4K
position
Trader 75CLong
$3K
position
Activist stakes, short interest & more
Earnings
Earnings came in 39.4% above what analysts expected.
Last report
Aug 5, 2026
Financial period
Q2 2026
Earnings per share
$6.01 expected
Revenue
No reported revenue on record
FY2026 guidance
$85.00B to $87.00B
No comparable estimate
At a glance
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $8.38 / $6.01Alpha Vantage | +39.43% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $8.55 / $6.79Alpha Vantage | +25.92% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $7.54 / $7.17Alpha Vantage | +5.16% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | $7.02 / $5.89Alpha Vantage | +19.19% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $6.31 / $5.61Alpha Vantage | +12.48% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 1, 2025 | $3.34 / $3.46Alpha Vantage | -3.47% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 6, 2025 | $5.32 / $5.07Alpha Vantage | +5.00% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $1.18 / $1.47Alpha Vantage | -19.73% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Oct 29, 2026, in 17 days
Estimates as of Oct 11, 2026
EPS expected
$9.23 to $11.30
Revenue expected
15 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $17.60B | $19.29B | $19.80B | $22.97B |
| Cost of what it sold | $3.01B | $3.37B | $3.58B | $3.27B |
| Gross profit | $14.59B | $15.92B | $16.22B | $19.71B |
| What it spent | ||||
| Research and development | $3.47B | $3.80B | $3.51B | $3.82B |
| Sales and admin | $2.74B | $3.34B | $2.93B | $3.43B |
| Other operating costs | — | -$212.1M | — | — |
| Total operating expenses | $6.21B | $6.93B | $6.44B | $7.25B |
| What was left | ||||
| Operating profit | $8.39B | $8.99B | $9.78B | $12.46B |
| Interest on debt | $179.6M | $123.0M | $332.0M | $345.0M |
| Profit before tax | $7.23B | $8.27B | $8.85B | $9.25B |
| Tax | $1.65B | $1.63B | $1.45B | $2.15B |
| Net profit | $5.58B | $6.64B | $7.40B | $7.09B |
| EBITDA | $7.88B | $12.14B | $10.29B | $12.99B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Bristol-Myers Squibb (BMY) Receives a Buy from J.P. Morgan
NeutralOct 9Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
Leans bullishOct 9AbbVie (ABBV) Receives a Buy from Cantor Fitzgerald
Leans bullishOct 9Rockwell Automation and Industry Leaders Launch the Digital CMC Consortium to Accelerate Digital Transformation in Pharmaceutical Development
Leans bullishOct 9Medical coding, GLP-1s push BCBSMA spending up 12%
Leans bullishOct 8Eli Lilly expanded Gate deal. Eli Lilly stock fell 4.08 percent
BearishOct 8Pfizer’s VESPER-OSA 1 Trial Targets Sleep Apnea and Obesity With Monthly Shot
NeutralOct 8Viatris boosts pain drug portfolio with $1.7B buyout of Pacira
NeutralOct 8
Macro
31 macro signals shaping LLY right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results